InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: buckiii2 post# 3835

Wednesday, 09/21/2016 4:30:30 PM

Wednesday, September 21, 2016 4:30:30 PM

Post# of 8449
KTOV a very professional report (link inside)-"patient population for KIT-302 of approximately 12 million patients in the US". "Figure 6 shows our estimates for US sales of KIT-302 based on the assumptions above. Our scenario includes a modest launch and peak penetration of 2%. This yields estimated peak sales of $513 million in 2022"
http://www.baystreet.ca/articles/research_reports/lifesci/Kitov092116.pdf

$22M cap, not for long imo.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.